Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Three years ago, I wrote about the incredibly low rates of PrEP use among teenagers — between 2018 and 2020, just 2% to 6% of sexually active LGBTQ adolescents in our studies had ever used PrEP ...

It is time for NHS England to "do the right thing" and fund pre-exposure prophylaxis (PrEP) for HIV prevention, argue two senior public health doctors.

PrEP (pre-exposure prophylaxis) is medicine that helps protect you from the human immunodeficiency virus (HIV), which causes AIDS. Learn about how it works, how well it works, who’s most likely ...

We’re at a time where we really need to think beyond incremental changes in access to PrEP, which have been very slow and certainly have not been putting us on the trajectory to meet the federal ...

The CDC has said that PrEP is a key prevention strategy for its Ending the HIV Epidemic in the U.S. initiative. The agency is aiming to get 50% of at-risk, HIV-negative people on PrEP by 2030 ...

PrEP is an antiretroviral medication proven to reduce HIV infections from sex by as much as 99%. It is sold as a daily pill under brand names Truvada and Descovy, as well as generic versions.

The PrEP gap. About 1.1 million Americans are at high risk for HIV and could benefit from PrEP, according to the CDC. Around half of those are black men and women, who have the highest HIV risk ...

The US Preventive Services Task Force recently issued a recommendation statement for preexposure prophylaxis (PrEP) for HIV, but it is so broadly worded that it will be subject to vast payer ...

A new study shows low rates of pre-exposure prophylaxis (PrEP) prescribing to sexual and gender minority individuals living ...

Taking PrEP before being exposed to the HIV virus means there’s enough of the drug inside you to block HIV if it gets into your body. ... and then daily during the time they are having sex.

The CDC has said that PrEP is a key prevention strategy for its Ending the HIV Epidemic in the U.S. initiative. The agency is aiming to get 50% of at-risk, HIV-negative people on PrEP by 2030 ...